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Development of tandem mass spectrometry-based creatinine measurement 
using dried blood spot for newborn mass screening. 
 
【Background】  
Congenital anomalies of the kidney and urinary tract (CAKUT) are the most prevalent 
etiologies of pediatric chronic kidney disease (CKD). It has been reported that early 
intervention for CAKUT can prevent disease progression. Therefore, early 
identification of patients  with CAKUT is crucial to protect the remaining renal function 
and to prevent complications in other organs due to CKD.   However, no robust mass 
screening methods have been developed to detect patients with CAKUT, making early 
intervention to prevent progressive renal failure challenging.  In Japan, newborn mass 
screening using tandem mass spectrometry (MS/MS) and dried blood spot (DBS) 
analysis for 19 inherited metabolic disorders has been in  effect since 2013. Therefore, 
renal function-based mass screening for CAKUT using the same DBS analysis is 
reasonable and applicable for all Japanese children. In the present study, we sought to 
establish a new method for mass screening of renal function using DBS analysis and 
MS/MS.  
【Methods】  
We applied  tandem mass spectrometry to measure the  creatinine  (Cr) value from dried 
blood spot analysis, which has been used for newborn mass screening. Subsequently, 
we evaluated the correlation between DBS Cr measured by MS/MS and serum Cr 
measured by the conventional method in pediatric patients with CKD. Finally, DBS Cr 
was measured in 190 full -term, healthy newborns on days 4-6 after birth.  
【Results】  
We established a system of MS/MS-based measurement of Cr from DBS. A 
high correlation (R = 0.863) of the serum Cr level with the DBS Cr level (0.5693 times 
lower than the serum Cr level) was observed in the full rang e. The median DBS Cr 
value in newborns was 0.222 (interquartile range: 0.189, 0.269) mg/dl. No significant 
correlations were found between DBS Cr  values and body weight, Apgar score, 
gestational age, and sex in newborns.  
【Conclusion】  
We have developed a new method of MS/MS-based measurement of DBS Cr, 
and we demonstrated that it is  practical, cost-effective, and could be used as a 
screening method to detect CAKUT  in the neonatal period. This method can be a 
realistic screening method with respect to the fact that nationwide screening is possible 
owing to the tandem mass screening method that is already in use.  Further studies 
involving more neonates  including CAKUT patients should be carried out.   
